Though not quite significant, there were trends towards higher insoluble UFSP2 levels in the temporal cortex of AD patients compared to controls (P = 0.050), and towards higher levels of insoluble UFM1 in the temporal cortex of AD patients, which also approached significance (P = 0.062) (Table 1). This evidence concerns the gene UFM1 and Alzheimer disease.